Vanguard Group Inc. Has $156.44 Million Stock Position in Pediatrix Medical Group, Inc. $MD

Key Points

• Vanguard Group Inc. currently holds a stock position worth $156.44 million in Pediatrix Medical Group, Inc., owning approximately 12.58% of the company after a slight decrease of 0.1% in shares.
• Pediatrix Medical Group recently reported an earnings per share (EPS) of $0.53, surpassing expectations of $0.42, even as quarterly revenue declined by 7.1% year-over-year.
• Analysts have given Pediatrix Medical Group a consensus rating of "Moderate Buy", with price targets ranging from $16.50 to $20.00.

Vanguard Group Inc. decreased its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 0.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,796,650 shares of the company's stock after selling 15,961 shares during the quarter. Vanguard Group Inc. owned approximately 12.58% of Pediatrix Medical Group worth $156,443,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. XTX Topco Ltd acquired a new position in shares of Pediatrix Medical Group during the 4th quarter worth $169,000. Principal Financial Group Inc. increased its stake in shares of Pediatrix Medical Group by 6.2% during the 1st quarter. Principal Financial Group Inc. now owns 586,190 shares of the company's stock worth $8,494,000 after purchasing an additional 34,266 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of Pediatrix Medical Group by 219.5% during the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock worth $37,000 after purchasing an additional 1,765 shares during the last quarter. SG Americas Securities LLC increased its stake in shares of Pediatrix Medical Group by 194.0% during the 1st quarter. SG Americas Securities LLC now owns 38,405 shares of the company's stock worth $556,000 after purchasing an additional 25,343 shares during the last quarter. Finally, Deutsche Bank AG lifted its stake in shares of Pediatrix Medical Group by 53.1% in the fourth quarter. Deutsche Bank AG now owns 74,023 shares of the company's stock worth $971,000 after buying an additional 25,663 shares during the last quarter. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Price Performance

NYSE:MD opened at $16.2760 on Thursday. The stock has a market cap of $1.42 billion, a P/E ratio of 12.62 and a beta of 1.21. Pediatrix Medical Group, Inc. has a one year low of $10.06 and a one year high of $17.67. The company has a fifty day moving average price of $13.67 and a 200 day moving average price of $13.90. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.80 and a quick ratio of 1.80.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.42 by $0.11. The firm had revenue of $468.84 million during the quarter, compared to analysts' expectations of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business's quarterly revenue was down 7.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.34 EPS. Analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analysts Set New Price Targets

MD has been the subject of a number of analyst reports. Zacks Research upgraded shares of Pediatrix Medical Group to a "strong-buy" rating in a research note on Monday, August 11th. UBS Group boosted their price objective on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. Finally, Macquarie boosted their price objective on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a research note on Thursday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $16.75.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.